|
|
NEW ON THE MARKET
|
|
Second SGLT2 inhibitor for type 2 diabetes mellitus: canagliflozin (INVOKANA)
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Withdrawal of approval: alternatives for metoclopramide drops (PASPERTIN, generics)
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Are there new data on ranolazine (RANEXA) for angina pectoris?
STADA-Diagnostik-DNA-Statine-Test: Does the gene test improve treatment with statins?
|
|
|
IN BRIEF
|
|
Stored neuraminidase inhibitors - an expensive "multi-system failure"
Quality review: olanzapine (ZYPREXA, generics) 10 mg tablets
|
|
Mammography: recommendation against screening programms in Switzerland
Medical apps may carry risks, but recalls are still rare
|
|
|
SIDE EFFECTS
|
|
Thrombotic microangiopathy with interferon beta (e.g. REBIF)
Administration error: do not inject the rotavirus vaccine ROTARIX
|
|
|
e a-t IN INTERNET
|
|
Advertising questioned: ESBERITOX COMPACT against common cold
|
|